Verweij
Adam Bastiaan Verweij, Aduard NL
Patent application number | Description | Published |
---|---|---|
20120149920 | Method for the production of a mixture of lactide derivatives - A mixture of cyclic diesters derived from lactic acid and in cases a mixture of a racemate of dilactide may be produced in several different processes. In some instances, the process can thereby start from the corresponding alpha-hydroxycarboxylic acids, the corresponding cyclic diesters or oligomers of the corresponding alpha-hydroxycarboxylic acids. | 06-14-2012 |
Antonie Hendrik Verweij, Dussen NL
Patent application number | Description | Published |
---|---|---|
20120075610 | LITHOGRAPHIC APPARATUS AND METHOD FOR REDUCING STRAY RADIATION - A lithographic apparatus includes an illumination system for providing a beam of extreme ultra-violet radiation, a masking device for controlling the illumination of a patterning device by the beam of radiation, a support for supporting the patterning device, the patterning device configured to impart a pattern to the beam of radiation, a substrate table for holding a substrate, and a projection system for projecting the patterned beam of radiation onto a target portion of the substrate. The masking device includes a masking blade including a masking edge configured to delimit a boundary of an illumination region on the patterning device. The masking blade is configured to reflect extreme ultra-violet radiation incident on the masking blade such that at least a portion of the reflected radiation is not captured by the projection system. | 03-29-2012 |
Cornelis Lammert Verweij, Abcoude NL
Patent application number | Description | Published |
---|---|---|
20100203523 | MEANS AND METHODS FOR CLASSIFYING SAMPLES OF MULTIPLE SCLEROSIS PATIENTS - The invention in one aspect provides a method for classifying cells from a human individual said method comprising: providing a sample comprising cells from said individual that are typically responsive to exposure to a type I interferon; determining a level of activity of a pathway that is modulated by type 1 interferon; and classifying said cells on the basis of the determined level of activity. Cells present in said sample are preferably cultured said cells in the presence of a type I interferon prior to determining a level of activity of said pathway. This is activity is preferably compared to the activity of said pathway in cells in said sample prior to said culture. Preferably the sample is from an individual that is not treated with a type I interferon prior to collecting said sample. Preferably the method is used to determine, prior to initiating treatment with a type I interferon, whether said individual is likely to be a good, a normal or a poor responder to the contemplated treatment. | 08-12-2010 |
20110091457 | METHOD FOR PROGNOSTICATING THE CLINICAL RESPONSE OF A PATIENT TO B-LYMPHOCYTE INHIBITING OR DEPLETING THERAPY - The invention relates to methods for predicting a clinical response to B-lymphocyte inhibiting or depleting therapies (BCIDT) using expression levels of genes of the Type I INF pathway. In another aspect, the invention relates to a method for evaluating a pharmacological effect of a treatment with B-lymphocyte inhibiting or depleting therapy. More in particular, the invention relates to a method for prognosticating the clinical response of a patient to treatment with a soluble BCID or TCID agent, said method comprising the steps of obtaining at least two samples from said patient wherein a first sample has not been exposed to a soluble BCID or TCID agent and wherein at least a second sample has been exposed to a soluble BCID or TCID agent, determining the level of an IFN-I type response in said at least two samples, comparing the level of the IFN-I type response in said first sample with the level of the IFN-1 type response in said at least second sample and prognosticating said clinical response from said comparison. | 04-21-2011 |
20110212849 | BIOMARKERS FOR PREDICTING THE DEVELOPMENT OF CHRONIC AUTOIMMUNE DISEASES - The invention relates to a method for determining whether an individual has an increased risk of developing symptoms of a chronic autoimmune disease comprising determining in a sample of said individual the levels of expression products of a collection of genes and determining whether the expression products are present at a level that is different when compared to the level of the same expression products of a control. Said collection of genes are selected from the group consisting of genes involved in the cellular process of (i) IFN-mediated immunity, (ii) hematopoiesis, (iii) B-cell mediated immunity and/or (iv) cytokine mediated immunity, wherein higher levels of expression products of genes involved in IFN-mediated immunity, hematopoiesis and cytokines are predictive for an increased risk and wherein higher levels of expression products of genes involved in the cellular process of B-cell mediated immunity are predictive for a decreased risk. | 09-01-2011 |
20140030261 | METHOD FOR PROGNOSTICATING THE CLINICAL RESPONSE OF A PATIENT TO B-LYMPHOCYTE INHIBITING OR DEPLETING THERAPY IN INTERFERON-DRIVEN DISEASES SUCH AS SLE - Described are methods for predicting a clinical response to B-lymphocyte inhibiting or depleting therapies (BCIDT) using expression levels of genes of the Type I INF pathway. In another aspect, the disclosure relates to a method for evaluating a pharmacological effect of a treatment with B-lymphocyte inhibiting or depleting therapy. More in particular, it relates to a method for prognosticating the clinical response of a patient to treatment with a soluble BCID or TCID agent, the method comprising the steps of obtaining at least two samples from the patient wherein a first sample has not been exposed to a soluble BCID or TCID agent and wherein at least a second sample has been exposed to a soluble BCID or TCID agent, determining the level of an IFN (preferably type I) response in the at least two samples, comparing the level of the IFN (preferably type I) response in the first sample with the level of the IFN (e.g., type I) response in the at least second sample and prognosticating the clinical response from the comparison. | 01-30-2014 |
20140094378 | MEANS AND METHODS FOR CLASSIFYING SAMPLES OF MULTIPLE SCLEROSIS PATIENTS - The invention in one aspect provides a method for classifying cells from a human individual said method comprising: providing a sample comprising cells from said individual that are typically responsive to exposure to a type I interferon; determining a level of activity of a pathway that is modulated by type I interferon; and classifying said cells on the basis of the determined level of activity. Cells present in said sample are preferably cultured said cells in the presence of a type I interferon prior to determining a level of activity of said pathway. This is activity is preferably compared to the activity of said pathway in cells in said sample prior to said culture. Preferably the sample is from an individual that is not treated with a type I interferon prior to collecting said sample. Preferably the method is used to determine, prior to initiating treatment with a type I interferon, whether said individual is likely to be a good, a normal or a poor responder to the contemplated treatment. | 04-03-2014 |
Dick Verweij, Nv Monster NL
Patent application number | Description | Published |
---|---|---|
20110113687 | METHOD AND SUBSTRATE FOR CULTIVATING A PLANT - A method for cultivating a plant, wherein a substrate is formed, in which substrate a seed or a root of the plant is placed, which substrate containing the seed or the plant is placed in a holder for the plant to grow, characterised in that at least two substrate parts are formed, with the seed or a root of the plant being placed between said at least two substrate parts before the substrate containing the seed or the plant is placed in the holder. | 05-19-2011 |
Hendrik Verweij, Upper Arlington, OH US
Patent application number | Description | Published |
---|---|---|
20100071556 | STABLE SUPPORTED Pd-ALLOY MEMBRANES - A Pd alloy membrane and method of making are described. | 03-25-2010 |
20110247492 | MODIFIED ZEOLITE Y MEMBRANES FOR HIGH-PERFORMANCE CO2 SEPARATION - Supported zeolite Y membranes exhibiting exceptionally high CO2 selectivities when used in CO | 10-13-2011 |
20120031833 | SYSTEMS, COMPOSITIONS, AND METHODS FOR FLUID PURIFICATION - Disclosed herein are membranes comprising a substrate, a support layer, and a selective layer. In some embodiments the membrane may further comprise a permeable layer. Methods of forming membranes are also disclosed comprising forming a support layer on a substrate, removing adsorbed species from the support layer, preparing a solution containing inorganic materials of a selective layer, contacting the support layer with the solution, drying the membrane, and exposing the membrane to rapid thermal processing. Also disclosed are methods of fluid purification comprising providing a membrane having a feed side and a permeable side, passing a fluid mixture across the feed side of the membrane, providing a driving force for transmembrane permeation, removing from the permeate side a permeate stream enriched in a purified fluid, and withdrawing from the feed side a fluid that is depleted in a purified fluid. | 02-09-2012 |
Henny Verweij, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20080215236 | Navigation device and method for using a traffic message channel - A method and a navigation device are disclosed for sharing at least one location message with at least one other device. The navigation device includes a receiver to receive multiple traffic message channels, an input device to receive a user input indicating a frequency, and a processor to select a traffic message channel based on a signal strength, starting with the indicated frequency. The method includes receiving multiple traffic message channels, receiving a user input indicating a frequency, and a selecting a traffic message channel based on a planned route, starting with the indicated frequency. | 09-04-2008 |
Jan Verweij, Ra Zoetermeer NL
Patent application number | Description | Published |
---|---|---|
20110041739 | ADJUSTING DEVICE - The invention, relates to an adjusting device, comprising an inner tubular body ( | 02-24-2011 |
Walker Verweij, Almere Buiten NL
Patent application number | Description | Published |
---|---|---|
20090217413 | PLANT GENETIC SEQUENCES ASSOCIATED WITH VACUOLAR PH AND USES THEREOF - The present invention relates generally to the field of plant molecular biology and agents useful in the manipulation of plant physiological or biochemical properties. More particularly, the present invention provides genetic and proteinaceous agents capable of modulating or altering the level of acidity or alkalinity in a cell, group of cells, organelle, part or reproductive portion of a plant. Even more particularly, the present invention contemplates methods and agents for modulating or altering pH levels in the vacuole of a cell, group of cells, organelle, part or reproductive portion of a plant. The present invention further provides genetically altered plants, plant parts, progeny, subsequent generations and reproductive material including flowers or flowering parts having cells exhibiting an altered vacuolar pH compared to a non-genetically altered plant. The present invention still further provides methods for modulating or altering flower color in a plant. Even more particularly, the present invention provides for down regulation of pH in a plant which results in a bluer color in the plant; especially in the flower | 08-27-2009 |
Walter Verweij, Almere Buiten NL
Patent application number | Description | Published |
---|---|---|
20090293144 | PLANT NUCLEIC ACIDS ASSOCIATED WITH CELLULAR pH AND USES THEREOF - The present invention relates generally to the field of plant molecular biology and agents useful in the manipulation of plant physiological or biochemical properties. More particularly, the present invention provides genetic and proteinaceous agents capable of modulating or altering the level of acidity or alkalinity in a cell, group of cells, organelle, part or reproductive portion of a plant. Genetically altered plants, plant parts, progeny, subsequent generations and reproductive material including flowers or flowering parts having cells exhibiting an altered cellular pH compared to a non-genetically altered plant are also provided. | 11-26-2009 |
Willem Marius Verweij, Schiedam NL
Patent application number | Description | Published |
---|---|---|
20150141232 | CENTRIFUGE - A centrifuge for high-speed centrifuging, includes: a shaft, mounted for continuous rotation about its axis, the shaft having a working section having a loading end and an unloading end; an acceleration member mounted adjacent to the loading end for rotation with respect to the shaft and; a deceleration member mounted adjacent to the unloading end for rotation with respect to the shaft; auxiliary drive arrangement for accelerating the acceleration member and the deceleration member to the shaft speed; carriages for supporting specimens for centrifugation. The carriages are slideably mounted for traversing from the acceleration member to the working section and from the working section to the deceleration member. A carriage may be accelerated on the acceleration member and then transferred to the working section for a period sufficient to perform centrifuging and then transferred from the working section to the deceleration member. | 05-21-2015 |
Willen Marius Verweij, Schiedam NL
Patent application number | Description | Published |
---|---|---|
20150141232 | CENTRIFUGE - A centrifuge for high-speed centrifuging, includes: a shaft, mounted for continuous rotation about its axis, the shaft having a working section having a loading end and an unloading end; an acceleration member mounted adjacent to the loading end for rotation with respect to the shaft and; a deceleration member mounted adjacent to the unloading end for rotation with respect to the shaft; auxiliary drive arrangement for accelerating the acceleration member and the deceleration member to the shaft speed; carriages for supporting specimens for centrifugation. The carriages are slideably mounted for traversing from the acceleration member to the working section and from the working section to the deceleration member. A carriage may be accelerated on the acceleration member and then transferred to the working section for a period sufficient to perform centrifuging and then transferred from the working section to the deceleration member. | 05-21-2015 |